A Reversal for WUXI BIOLOGICS CAYMAN INC ORDINARY SHARE (OTCMKTS:WXIBF) Is Near. The Stock Has Decrease in Shorts

June 15, 2018 - By Kenneth Lin

The stock of WUXI BIOLOGICS CAYMAN INC ORDINARY SHARE (OTCMKTS:WXIBF) registered a decrease of 90.39% in short interest. WXIBF’s total short interest was 116,000 shares in June as published by FINRA. Its down 90.39% from 1.21M shares, reported previously. With 9,100 shares average volume, it will take short sellers 13 days to cover their WXIBF’s short positions.

It closed at $12 lastly. It is down 0.00% since June 15, 2017 and is . It has underperformed by 12.57% the S&P500.

WuXi Biologics Inc., an investment holding company, provides integrated biologics outsourcing services worldwide. The company has market cap of $13.81 billion. The firm offers services for the discovery, development, and manufacture of biologics, such as monoclonal antibodies, recombinant therapeutic proteins, fusion proteins, vaccines, blood and blood components, allergenics, somatic cells, gene therapy, and tissues. It currently has negative earnings. It serves pharmaceutical and biotechnology companies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: